What is NeoGenomics's payments to notes receivables?

NeoGenomics (NEO) reported payments to notes receivables of $125K in Q4 2025.

What does payments to notes receivables mean?

This represents cash outflows used to acquire notes receivable or provide loans to third parties as part of the company's investing activities. It reflects the deployment of capital into debt-like instruments rather than core operational growth.

NeoGenomics NEO Payments to notes receivables

Payments to notes receivables at other companies

Agilent TechnologiesA

$1M—

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B-21.0%

Enterprise value$1.6B-5.6%

P/S2.3×-0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireNotesReceivable.

The official record: NeoGenomics’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's payments to notes receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's payments to notes receivables?: NeoGenomics (NEO) reported payments to notes receivables of $125K in Q4 2025.
What does payments to notes receivables mean?: This represents cash outflows used to acquire notes receivable or provide loans to third parties as part of the company's investing activities. It reflects the deployment of capital into debt-like instruments rather than core operational growth.